<VariationArchive VariationID="2425632" VariationName="NC_000019.9:g.(?_7617787)_(7622096_?)del" VariationType="Deletion" Accession="VCV002425632" Version="3" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-10" DateCreated="2023-02-13" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1939640" VariationID="2425632">
      <GeneList>
        <Gene Symbol="PNPLA6" FullName="patatin like phospholipase domain containing 6" GeneID="10908" HGNC_ID="HGNC:16268" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19p13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="7534164" stop="7561767" display_start="7534164" display_stop="7561767" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="7599037" stop="7626652" display_start="7599037" display_stop="7626652" Strand="+" />
          </Location>
          <OMIM>603197</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000019.9:g.(?_7617787)_(7622096_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19p13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" innerStart="7617787" innerStop="7622096" display_start="7617787" display_stop="7622096" variantLength="4310" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.(?_7617787)_(7622096_?)del" Assembly="GRCh37">
            <Expression>NC_000019.9:g.(?_7617787)_(7622096_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000019.9:g.(?_7617787)_(7622096_?)del AND Hereditary spastic paraplegia 39" Accession="RCV003109556" Version="3">
        <ClassifiedConditionList TraitSetID="1828">
          <ClassifiedCondition DB="MedGen" ID="C2677586">Hereditary spastic paraplegia 39</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-09-28" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-13" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16199547</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24355708</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25267340</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33141049</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1828" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3805" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="612020" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603197.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603197.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603197.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603197.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603197.0002" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spastic paraplegia 39</ElementValue>
                <XRef ID="Spastic+paraplegia+39/6694" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">NTE related motor neuron disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary spastic paraplegia 39</ElementValue>
                <XRef ID="MONDO:0012787" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">SPG39</ElementValue>
                <XRef Type="MIM" ID="612020" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">NTEMND</ElementValue>
                <XRef Type="MIM" ID="612020" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">PNPLA6 disorders span a phenotypic continuum characterized by variable combinations of cerebellar ataxia; upper motor neuron involvement manifesting as spasticity and/or brisk reflexes; chorioretinal dystrophy associated with variable degrees of reduced visual function; and hypogonadotropic hypogonadism (delayed puberty and lack of secondary sex characteristics). The hypogonadotropic hypogonadism occurs either in isolation or as part of anterior hypopituitarism (growth hormone, thyroid hormone, or gonadotropin deficiencies). Common but less frequent features are peripheral neuropathy (usually of axonal type manifesting as reduced distal reflexes, diminished vibratory sensation, and/or distal muscle wasting); hair anomalies (long eyelashes, bushy eyebrows, or scalp alopecia); short stature; and impaired cognitive functioning (learning disabilities in children; deficits in attention, visuospatial abilities, and recall in adults). Some of these features can occur in distinct clusters on the phenotypic continuum: Boucher-Neuhäuser syndrome (cerebellar ataxia, chorioretinal dystrophy, and hypogonadotropic hypogonadism); Gordon Holmes syndrome (cerebellar ataxia, hypogonadotropic hypogonadism, and – to a variable degree – brisk reflexes); Oliver-McFarlane syndrome (trichomegaly, chorioretinal dystrophy, short stature, intellectual disability, and hypopituitarism); Laurence-Moon syndrome; and spastic paraplegia type 39 (SPG39) (upper motor neuron involvement, peripheral neuropathy, and sometimes reduced cognitive functioning and/or cerebellar ataxia).</Attribute>
                <XRef ID="NBK247161" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4924" />
                <XRef ID="4924" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">25299038</ID>
                <ID Source="BookShelf">NBK247161</ID>
              </Citation>
              <XRef ID="139480" DB="Orphanet" />
              <XRef ID="C2677586" DB="MedGen" />
              <XRef ID="MONDO:0012787" DB="MONDO" />
              <XRef Type="MIM" ID="612020" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7074535" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2023-02-13">
        <ClinVarSubmissionID localKey="NM_006702.4_19_Partial deletion (exons 22-30)_7617786_7622096|MedGen:C2677586" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003791539" DateUpdated="2024-06-09" DateCreated="2023-02-13" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24355708</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25267340</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33141049</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16199547</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24355708</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the PNPLA6 protein in which other variant(s) (p.Ser997Leu) have been determined to be pathogenic (PMID: 24355708, 25267340, 33141049). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant has not been reported in the literature in individuals affected with PNPLA6-related conditions. This variant results in the deletion of exons 22-29 and part of exon 30 (c.2144-968_3212del) of the PNPLA6 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in PNPLA6 are known to be pathogenic (PMID: 24355708).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PNPLA6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.(?_7617787)_(7622096_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2677586" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7074535" TraitType="Disease" MappingType="XRef" MappingValue="C2677586" MappingRef="MedGen">
        <MedGen CUI="C2677586" Name="Hereditary spastic paraplegia 39" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

